167 related articles for article (PubMed ID: 15969888)
1. A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products.
Cowden DI; Fisher GE; Weeks RL
Curr Med Res Opin; 2005 Jun; 21(6):877-83. PubMed ID: 15969888
[TBL] [Abstract][Full Text] [Related]
2. Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy.
Kolarich D; Turecek PL; Weber A; Mitterer A; Graninger M; Matthiessen P; Nicolaes GA; Altmann F; Schwarz HP
Transfusion; 2006 Nov; 46(11):1959-77. PubMed ID: 17076852
[TBL] [Abstract][Full Text] [Related]
3. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
Louie SG; Sclar DA; Gill MA
Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
[TBL] [Abstract][Full Text] [Related]
4. Biochemical comparison of four commercially available human α
Boerema DJ; An B; Gandhi RP; Papineau R; Regnier E; Wilder A; Molitor A; Tang AP; Kee SM
Biologicals; 2017 Nov; 50():63-72. PubMed ID: 28882403
[TBL] [Abstract][Full Text] [Related]
5. Characterization of antithrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods.
Kremser L; Brückner A; Heger A; Grunert T; Buchacher A; Josic D; Allmaier G; Rizzi A
Electrophoresis; 2003 Dec; 24(24):4282-90. PubMed ID: 14679575
[TBL] [Abstract][Full Text] [Related]
6. Determination of the site-specific and isoform-specific glycosylation in human plasma-derived antithrombin by IEF and capillary HPLC-ESI-MS/MS.
Plematl A; Demelbauer UM; Josic D; Rizzi A
Proteomics; 2005 Oct; 5(15):4025-33. PubMed ID: 16145710
[TBL] [Abstract][Full Text] [Related]
7. Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release.
Nita I; Hollander C; Westin U; Janciauskiene SM
Respir Res; 2005 Jan; 6(1):12. PubMed ID: 15683545
[TBL] [Abstract][Full Text] [Related]
8. Commercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent component.
Lomas DA; Elliott PR; Carrell RW
Eur Respir J; 1997 Mar; 10(3):672-5. PubMed ID: 9073003
[TBL] [Abstract][Full Text] [Related]
9. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Biochemical Efficacy of an α
Li Z; Franke RM; Morris DN; Yel L
Pulm Ther; 2022 Sep; 8(3):311-326. PubMed ID: 36001294
[TBL] [Abstract][Full Text] [Related]
11. Alpha 1-antitrypsin augmentation therapy.
Sandhaus RA
Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
[TBL] [Abstract][Full Text] [Related]
12. A zone electrophoretic-isoelectric focusing study on the inactivation of human alpha 1-antitrypsin by elastase.
Baumstark JS
Appl Theor Electrophor; 1988; 1(1):65-71. PubMed ID: 3154962
[TBL] [Abstract][Full Text] [Related]
13. Purification of alpha 1 proteinase inhibitor from human plasma fraction IV-1 by ion exchange chromatography.
Chen SX; Hammond DJ; Lang JM; Lebing WR
Vox Sang; 1998; 74(4):232-41. PubMed ID: 9691404
[TBL] [Abstract][Full Text] [Related]
14. Analysis and determination of biological activity of short-chain peptides from porcine brain hydrolysate.
Zhang H; Zhang X; Xu B
J Pharm Biomed Anal; 2005 Feb; 37(2):333-9. PubMed ID: 15708675
[TBL] [Abstract][Full Text] [Related]
15. Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira.
Stocks JM; Brantly M; Pollock D; Barker A; Kueppers F; Strange C; Donohue JF; Sandhaus R
COPD; 2006 Mar; 3(1):17-23. PubMed ID: 17175661
[TBL] [Abstract][Full Text] [Related]
16. Serum alpha-1 proteinase inhibitor in advanced cancer: mass variants and functionally inert forms.
Chawla RK; Lawson DH; Sarma PR; Nixon DW; Travis J
Cancer Res; 1987 Feb; 47(4):1179-84. PubMed ID: 3492270
[TBL] [Abstract][Full Text] [Related]
17. Pathogen safety and characterisation of a highly purified human alpha
Kee S; Weber D; Popp B; Nowak T; Schäfer W; Gröner A; Roth NJ
Biologicals; 2017 May; 47():25-32. PubMed ID: 28377078
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human bone alkaline phosphatase isoforms: comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography.
Sharp CA; Linder C; Magnusson P
Clin Chim Acta; 2007 Apr; 379(1-2):105-12. PubMed ID: 17289010
[TBL] [Abstract][Full Text] [Related]
19. Rapid separation of protein isoforms by capillary zone electrophoresis with new dynamic coatings.
Chang WW; Hobson C; Bomberger DC; Schneider LV
Electrophoresis; 2005 Jun; 26(11):2179-86. PubMed ID: 15861468
[TBL] [Abstract][Full Text] [Related]
20. Analysis of cross-linked human hemoglobin by conventional isoelectric focusing, immobilized pH gradients, capillary electrophoresis, and mass spectrometry.
Bossi A; Patel MJ; Webb EJ; Baldwin MA; Jacob RJ; Burlingame AL; Righetti PG
Electrophoresis; 1999 Oct; 20(14):2810-7. PubMed ID: 10546811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
